
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Etravirine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Recipient : Bionpharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Bionpharma Gets USFDA Nod for Etravirine Tablets with STEERLife
Details : Etravirine, a miscellaneous product, targets human immunodeficiency virus type 1 reverse transcriptase, focusing on treating HIV/AIDS.
Product Name : Intelence-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 13, 2026
Lead Product(s) : Etravirine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Recipient : Bionpharma
Deal Size : Inapplicable
Deal Type : Inapplicable
